Today many speak about crisis. The factories are closed, many enterprises appear unprofitable, did not become a rarity of the message on bankruptcy industrial giants.
On this background start in operation of a new industrial platform of a leading Russian pharmaceutical company "АBOLmed"LLC seems simply a fantasy.




New manufacturing line, as well as all enterprise "АBOLmed" LLC in Novosibirsk, it is constructed from zero, without money from the federal budget. The distinctive feature is the new equipment produced and mounted by the leader in production and service of lines for pharmaceutical industry by Italian company IMA. To begin work on completely automated line, experts of "АBOLmed" LLC had training preparation and training abroad. However the most important is a complete conformity of new production to branch GMP standard. As to introduction and observance of standards of "good manufacturing practice” of production of medicines (so it is literally possible to decipher abbreviation GMP) without which not possible to realize first-class pharmaceutical business, "АBOLmed" LLC was the first who has realized in practice these position not in frameworks of one shop, and in major concern scales.



The basic direction of activity of a new industrial platform – production of solutions of antibacterial preparations which are the major READY-TO-USE parenteral form of antibiotics for hospitals. Today it is the most demanded in clinics fluorquinolones, one of the most perspective classes of medical products for treatment of infections of the most various localisations. Scheduled tendency is wider inclusion fluorquinolones in schemes and protocols of antimicrobic therapy that, accordingly, requires availability in hospitals qualitative and effective antibacterials of this group.The basic direction of activity of a new industrial platform – production of solutions of antibacterial preparations which are the major READY-TO-USE parenteral form of antibiotics for hospitals. Today it is the most demanded in clinics fluorquinolones, one of the most perspective classes of medical products for treatment of infections of the most various localisations. Scheduled tendency is wider inclusion fluorquinolones in schemes and protocols of antimicrobic therapy that, accordingly, requires availability in hospitals qualitative and effective antibacterials of this group.



Thereupon, realising the next stage of the program of accessible qualitative medicines, "АBOLmed" LLC plans to ensure domestic establishments of public health institutions with quality and effective fluorquinolones. Thereupon, realising the next stage of the program of accessible qualitative medicines, "АBOLmed" LLC plans to ensure domestic establishments of public health institutions with quality and effective fluorquinolones.